Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has opened a new office space at Granta Park in Cambridgeshire, UK. The new facilities support the Company’s accelerated expansion and accommodate its plans for further growth.

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK
McClintock Building, Granta Park. Image credit: Sphere Fluidics

Sphere Fluidics recently closed a $4.8 million USD (£3.7 million) funding round, enabling it to hire 10 new staff to expand commercial capabilities and facilitate service and support for its Cyto-Mine® Single Cell Analysis System. Sphere Fluidics sales, marketing, finance and operations teams join the specialist skills pool at Granta Park, one of the UK’s leading life-science research parks, positioned within the Cambridge Science Cluster, taking 1,038 sq. ft in the McClintock Building. The Park is home to over 2,500 people and multiple organizations, placing the Company in close proximity to high-quality research and commercialization activity, and opening up the opportunity for further collaborations with potential partners, researchers and suppliers based on the campus.

Sphere Fluidics’ new facilities at Granta Park are in addition to its offices at Babraham Research Campus, Cambridgeshire, UK and Monmouth Junction, New Jersey, USA. The Company also has an established network of international distributors in Japan, France, China, Switzerland, Germany, Austria, Benelux, Australia, Scandinavia and Korea.

Rob Treanor, Director of Operations, Sphere Fluidics, commented:

Recent investment has enabled Sphere Fluidics to accelerate its plans to expand commercial and scientific activities and we are now raising further funding to invest in more new hires and increase our presence in not only the UK but also, the US. It is vital that we are positioned in locations with a flexible and innovative network and look forward to joining the collaborative culture at Granta Park to support these growth projections.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sphere Fluidics. (2020, May 13). Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20191016/Sphere-Fluidics-expands-into-additional-facility-at-Granta-Park-in-Cambridge-UK.aspx.

  • MLA

    Sphere Fluidics. "Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20191016/Sphere-Fluidics-expands-into-additional-facility-at-Granta-Park-in-Cambridge-UK.aspx>.

  • Chicago

    Sphere Fluidics. "Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK". News-Medical. https://www.news-medical.net/news/20191016/Sphere-Fluidics-expands-into-additional-facility-at-Granta-Park-in-Cambridge-UK.aspx. (accessed November 21, 2024).

  • Harvard

    Sphere Fluidics. 2020. Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20191016/Sphere-Fluidics-expands-into-additional-facility-at-Granta-Park-in-Cambridge-UK.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows